Francesca Pia Panaccione, Sofia Mongardi, Marco Masseroli, Pietro Pinoli
{"title":"BioGAN:利用生物学知识增强转录组学数据生成。","authors":"Francesca Pia Panaccione, Sofia Mongardi, Marco Masseroli, Pietro Pinoli","doi":"10.3390/bioengineering12060658","DOIUrl":null,"url":null,"abstract":"<p><p>The advancement of computational genomics has significantly enhanced the use of data-driven solutions in disease prediction and precision medicine. Yet, challenges such as data scarcity, privacy constraints, and biases persist. Synthetic data generation offers a promising solution to these issues. However, existing approaches based on generative artificial intelligence often fail to incorporate biological knowledge, limiting the realism and utility of generated samples. In this work, we present BioGAN, a novel generative framework that, for the first time, incorporates graph neural networks into a generative adversarial network architecture for transcriptomic data generation. By leveraging gene regulatory and co-expression networks, our model preserves biological properties in the generated transcriptomic profiles. We validate its effectiveness on <i>E. coli</i> and human gene expression datasets through extensive experiments using unsupervised and supervised evaluation metrics. The results demonstrate that incorporating a priori biological knowledge is an effective strategy for enhancing both the quality and utility of synthetic transcriptomic data. On human data, BioGAN achieves a 4.3% improvement in precision and an up to 2.6% higher correlation with real profiles compared to state-of-the-art models. In downstream disease and tissue classification tasks, our synthetic data improves prediction performance by an average of 5.7%. Results on <i>E. coli</i> further confirm BioGAN's robustness, showing consistently strong recall and predictive utility.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 6","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189748/pdf/","citationCount":"0","resultStr":"{\"title\":\"BioGAN: Enhancing Transcriptomic Data Generation with Biological Knowledge.\",\"authors\":\"Francesca Pia Panaccione, Sofia Mongardi, Marco Masseroli, Pietro Pinoli\",\"doi\":\"10.3390/bioengineering12060658\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The advancement of computational genomics has significantly enhanced the use of data-driven solutions in disease prediction and precision medicine. Yet, challenges such as data scarcity, privacy constraints, and biases persist. Synthetic data generation offers a promising solution to these issues. However, existing approaches based on generative artificial intelligence often fail to incorporate biological knowledge, limiting the realism and utility of generated samples. In this work, we present BioGAN, a novel generative framework that, for the first time, incorporates graph neural networks into a generative adversarial network architecture for transcriptomic data generation. By leveraging gene regulatory and co-expression networks, our model preserves biological properties in the generated transcriptomic profiles. We validate its effectiveness on <i>E. coli</i> and human gene expression datasets through extensive experiments using unsupervised and supervised evaluation metrics. The results demonstrate that incorporating a priori biological knowledge is an effective strategy for enhancing both the quality and utility of synthetic transcriptomic data. On human data, BioGAN achieves a 4.3% improvement in precision and an up to 2.6% higher correlation with real profiles compared to state-of-the-art models. In downstream disease and tissue classification tasks, our synthetic data improves prediction performance by an average of 5.7%. Results on <i>E. coli</i> further confirm BioGAN's robustness, showing consistently strong recall and predictive utility.</p>\",\"PeriodicalId\":8874,\"journal\":{\"name\":\"Bioengineering\",\"volume\":\"12 6\",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189748/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3390/bioengineering12060658\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12060658","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
BioGAN: Enhancing Transcriptomic Data Generation with Biological Knowledge.
The advancement of computational genomics has significantly enhanced the use of data-driven solutions in disease prediction and precision medicine. Yet, challenges such as data scarcity, privacy constraints, and biases persist. Synthetic data generation offers a promising solution to these issues. However, existing approaches based on generative artificial intelligence often fail to incorporate biological knowledge, limiting the realism and utility of generated samples. In this work, we present BioGAN, a novel generative framework that, for the first time, incorporates graph neural networks into a generative adversarial network architecture for transcriptomic data generation. By leveraging gene regulatory and co-expression networks, our model preserves biological properties in the generated transcriptomic profiles. We validate its effectiveness on E. coli and human gene expression datasets through extensive experiments using unsupervised and supervised evaluation metrics. The results demonstrate that incorporating a priori biological knowledge is an effective strategy for enhancing both the quality and utility of synthetic transcriptomic data. On human data, BioGAN achieves a 4.3% improvement in precision and an up to 2.6% higher correlation with real profiles compared to state-of-the-art models. In downstream disease and tissue classification tasks, our synthetic data improves prediction performance by an average of 5.7%. Results on E. coli further confirm BioGAN's robustness, showing consistently strong recall and predictive utility.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering